Cody E. Cotner
Impact in
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Cells and Metastasis
- Peptidase Inhibition and Analysis
- Cancer Immunotherapy and Biomarkers
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 3
- COVID-19 and healthcare impacts 2
- Peptidase Inhibition and Analysis 1
-
- Multiple and Secondary Primary Cancers 1
- Mycobacterium research and diagnosis 1
- Co-authors
- Ellen Puré (1 shared paper)Laura A. Johnson (1 shared paper)Carl H. June (1 shared paper)Amy C. Durham (1 shared paper)R. Sonali Majumdar (1 shared paper)Steven Μ. Albelda (1 shared paper)Charalambos Solomides (1 shared paper)Albert Lo (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Cancer Immunology Research (1 paper)JCO Clinical Cancer Informatics (1 paper)Urologic Oncology Seminars and Original Investigations (1 paper)Journal of Pain and Symptom Management (1 paper)
- Partner nations
- United StatesSwitzerlandCanada
In The Last Decade
Cody E. Cotner
9 papers receiving 563 citations
Cody E. Cotner's Hit Papers
Peers
Comparison fields: 5 of 43
- Oncology 467
- Immunology 173
- Cancer Research 58
- Genetics 85
- Biomedical Engineering 124
Countries citing papers authored by Cody E. Cotner
This map shows the geographic impact of Cody E. Cotner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cody E. Cotner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cody E. Cotner more than expected).
Fields of papers citing papers by Cody E. Cotner
This network shows the impact of papers produced by Cody E. Cotner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cody E. Cotner. The network helps show where Cody E. Cotner may publish in the future.
Co-authors
The 25 scholars most cited alongside Cody E. Cotner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity Hit paper breakdown → | 2013 | 543 |
| 2 | 2020 | 11 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 3 | |
| 5 | 2020 | 3 | |
| 6 | 2024 | 2 | |
| 7 | 2021 | 1 | |
| 8 | 2023 | 1 | |
| 9 | 2021 | 1 | |
| 10 | 2024 | 0 |
About Cody E. Cotner
Cody E. Cotner is a scholar working on Oncology, Epidemiology, Economics and Econometrics, Surgery and General Health Professions, having authored 10 papers that have together received 568 indexed citations. Recurring topics across this work include COVID-19 and healthcare impacts (2 papers), Multiple and Secondary Primary Cancers (1 paper), Radiomics and Machine Learning in Medical Imaging (1 paper), Healthcare cost, quality, practices (1 paper), Cancer Genomics and Diagnostics (1 paper), Mycobacterium research and diagnosis (1 paper), Peptidase Inhibition and Analysis (1 paper) and Health Systems, Economic Evaluations, Quality of Life (1 paper). The work is most often cited by research in Oncology (467 citations), Immunology (173 citations), Cancer Research (58 citations), Genetics (85 citations) and Biomedical Engineering (124 citations). Cody E. Cotner has collaborated with scholars based in United States, Switzerland and Canada. Frequent co-authors include Ellen Puré, Laura A. Johnson, Carl H. June, Amy C. Durham, R. Sonali Majumdar, Steven Μ. Albelda, Charalambos Solomides, Albert Lo, Veena Kapoor and Liang‐Chuan S. Wang. Their work appears in journals such as Journal of Clinical Oncology, Cancer Immunology Research, JCO Clinical Cancer Informatics, Urologic Oncology Seminars and Original Investigations and Journal of Pain and Symptom Management.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.